Epidemiology and natural history of non-alcoholic fatty liver disease.

[1]  L. Henry,et al.  Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis , 2016, Expert review of gastroenterology & hepatology.

[2]  L. Henry,et al.  Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 , 2015, Hepatology.

[3]  T. Saibara,et al.  A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers , 2015, Hepatology.

[4]  E. Bjornsson,et al.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.

[5]  Xiao-dong Guo,et al.  Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis , 2015, PloS one.

[6]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[7]  Anthony Gamst,et al.  Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study , 2014, Hepatology.

[8]  Jen-Jung Pan,et al.  Gender and racial differences in nonalcoholic fatty liver disease. , 2014, World journal of hepatology.

[9]  K. Kowdley,et al.  Controversies in the Diagnosis and Management of NAFLD and NASH. , 2014, Gastroenterology & hepatology.

[10]  B. Neuschwander‐Tetri,et al.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients , 2013, Hepatology.

[11]  Luca Valenti,et al.  Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment , 2013, Current pharmaceutical design.

[12]  Eliseo Guallar,et al.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2013, American journal of epidemiology.

[13]  V. Wong,et al.  NAFLD in Asia—as common and important as in the West , 2013, Nature Reviews Gastroenterology &Hepatology.

[14]  M. Bulsara,et al.  High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis , 2013, Clinical chemistry and laboratory medicine.

[15]  G. Musso,et al.  Association of obstructive sleep apnoea with the presence and severity of non‐alcoholic fatty liver disease. A systematic review and meta‐analysis , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[16]  T. Berg,et al.  Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[17]  E. Manzato,et al.  Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society , 2013, Acta Diabetologica.

[18]  M. Lazo,et al.  Racial Differences in Nonalcoholic Fatty Liver Disease in the U.S. Population , 2013, Obesity.

[19]  Grace Lai-Hung Wong,et al.  Update of liver fibrosis and steatosis with transient elastography (Fibroscan) , 2013, Gastroenterology report.

[20]  Z. Younossi,et al.  In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. , 2013, Metabolism: clinical and experimental.

[21]  F. Negro,et al.  Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States , 2012, Medicine.

[22]  A. McCullough,et al.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD. , 2012, Gastroenterology & hepatology.

[23]  M. Duvnjak,et al.  Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. , 2012, World journal of gastroenterology.

[24]  Y. Yılmaz.  Review article: non‐alcoholic fatty liver disease and osteoporosis – clinical and molecular crosstalk , 2012, Alimentary pharmacology & therapeutics.

[25]  A. Tsung,et al.  Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease , 2012, Hepatology.

[26]  H. Ferral,et al.  Transjugular Liver Biopsy , 2012, Seminars in Interventional Radiology.

[27]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[28]  K. Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[29]  K. Flegal,et al.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. , 2012, JAMA.

[30]  A. Pollett,et al.  Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients , 2012, Hepatology.

[31]  M. Ekstedt,et al.  Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression , 2012, Scandinavian journal of gastroenterology.

[32]  H. J. de Silva,et al.  Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka , 2011, BMC Research Notes.

[33]  G. Musso,et al.  Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity , 2011, Annals of medicine.

[34]  Robert C Oh,et al.  Causes and evaluation of mildly elevated liver transaminase levels. , 2011, American family physician.

[35]  J. Heimbach,et al.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.

[36]  D. Burns,et al.  Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[37]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[38]  N. Chalasani,et al.  Endpoints and clinical trial design for nonalcoholic steatohepatitis , 2011, Hepatology.

[39]  Jonah N Rubin,et al.  Non‐alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do , 2011, Diabetes/metabolism research and reviews.

[40]  H. Makhlouf,et al.  Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality , 2011, Hepatology.

[41]  M. Stepanova,et al.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  T. Saibara,et al.  Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  A. Baranova,et al.  A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis , 2011, Obesity surgery.

[44]  B. Neuschwander‐Tetri,et al.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.

[45]  Udo Hoffmann,et al.  Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits , 2011, PLoS genetics.

[46]  William M. Lee,et al.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  A. Feldstein,et al.  Nonalcoholic steatohepatitis: risk factors and diagnosis , 2010, Expert review of gastroenterology & hepatology.

[48]  C. Byrne,et al.  Obstructive sleep apnea syndrome and fatty liver: association or causal link? , 2010, World journal of gastroenterology.

[49]  B. Neuschwander‐Tetri,et al.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease , 2010, Hepatology.

[50]  M. Stepanova,et al.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study , 2010, Gut.

[51]  Vincent Wai-Sun Wong,et al.  Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years , 2010, Gut.

[52]  H. Lee,et al.  Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology , 2010, Hepatology.

[53]  S. Caldwell,et al.  The Natural History of Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[54]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[55]  E. Bugianesi,et al.  Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease , 2010, Hepatology.

[56]  J. Ahmad,et al.  Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[57]  J Bernadette Moore,et al.  Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome , 2010, Proceedings of the Nutrition Society.

[58]  Julien Vergniol,et al.  Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.

[59]  T. Joh,et al.  Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup , 2010, Journal of gastroenterology and hepatology.

[60]  Greger Lindberg,et al.  Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.

[61]  Nick V. Grishin,et al.  A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.

[62]  Z. Goodman,et al.  Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[63]  A. Feldstein,et al.  Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.

[64]  J. Newton,et al.  Non-Alcoholic Fatty Liver Disease in Older People , 2009, Gerontology.

[65]  A. Kasturiratne,et al.  Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population , 2009, Journal of gastroenterology and hepatology.

[66]  J. Rotter,et al.  Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort , 2009, Obesity.

[67]  B. Heniford,et al.  Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[68]  D. Huo,et al.  Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. , 2009, Journal of hepatology.

[69]  Joshi,et al.  Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. , 2009, The Journal of the Association of Physicians of India.

[70]  Chunhong Bai,et al.  Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[71]  Katsutoshi Tokushige,et al.  Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C , 2009, Journal of gastroenterology and hepatology.

[72]  G. Salles,et al.  Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[73]  D. Torres,et al.  Nonalcoholic fatty liver disease. , 2008, Clinics in liver disease.

[74]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[75]  Z. Younossi,et al.  Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. , 2008, Journal of hepatology.

[76]  Z. Goodman,et al.  Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[77]  Zhou-wen Chen,et al.  Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease , 2008, Journal of Zhejiang University SCIENCE B.

[78]  C. Sirlin,et al.  Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.

[79]  E. Vittinghoff,et al.  A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients , 2008, Hepatology.

[80]  Giorgio Brunello,et al.  Rise in obesity across the Atlantic: an economic perspective , 2008 .

[81]  K-U. Lee,et al.  Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[82]  M. Lazo,et al.  Brief Communication: Clinical Implications of Short-Term Variability in Liver Function Test Results , 2008, Annals of Internal Medicine.

[83]  J. Keijer,et al.  Adipose tissue failure and mitochondria as a possible target for improvement by bioactive food components , 2008, Current opinion in lipidology.

[84]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[85]  Richard L Ehman,et al.  Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications , 2007, Hepatology.

[86]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[87]  G. Bedogni,et al.  Incidence and natural course of fatty liver in the general population: The Dionysos study , 2007, Hepatology.

[88]  M. Tsutsumi,et al.  Usefulness of a Combined Evaluation of the Serum Adiponectin Level, HOMA-IR, and Serum Type IV Collagen 7S Level to Predict the Early Stage of Nonalcoholic Steatohepatitis , 2007, The American Journal of Gastroenterology.

[89]  Chien-Hua Chen,et al.  Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan , 2007, Journal of gastroenterology and hepatology.

[90]  J. Miquel,et al.  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. , 2007, Journal of hepatology.

[91]  E. Yu,et al.  Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. , 2007, Journal of hepatology.

[92]  Khean-Lee Goh,et al.  How common is non‐alcoholic fatty liver disease in the Asia–Pacific region and are there local differences? , 2007, Journal of gastroenterology and hepatology.

[93]  T. Saibara,et al.  Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines , 2007, Journal of gastroenterology and hepatology.

[94]  Jian-Gao Fan,et al.  The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers , 2007, Journal of gastroenterology and hepatology.

[95]  A. Nakajima,et al.  Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) , 2007, Gut.

[96]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[97]  P. Puvanachandra,et al.  Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs. , 2007, Clinical medicine.

[98]  J. Takeda,et al.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. , 2007, World journal of gastroenterology.

[99]  Zhong-li Wang,et al.  Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China , 2007, Postgraduate Medical Journal.

[100]  J. Machan,et al.  Nonalcoholic Fatty Liver Disease in Severely Obese Subjects , 2007, The American Journal of Gastroenterology.

[101]  T. Setji,et al.  Polycystic ovary syndrome: diagnosis and treatment. , 2007, The American journal of medicine.

[102]  Z. Younossi,et al.  Epidemiology and natural history of NAFLD and NASH. , 2007, Clinics in liver disease.

[103]  J. Adams,et al.  Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. , 2006, The Journal of clinical endocrinology and metabolism.

[104]  Dominique Thabut,et al.  Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.

[105]  H. Cortez‐Pinto,et al.  Hepatic histology in obese patients undergoing bariatric surgery. , 2006, Journal of hepatology.

[106]  A. Lazenby,et al.  The Prevalence of Nonalcoholic Steatohepatitis is Greater in Morbidly Obese Men Compared to Women , 2006, Obesity surgery.

[107]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[108]  Robert A Fisher,et al.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.

[109]  Steven P. Larson,et al.  Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[110]  S. Msika,et al.  Prevalence and Predictive Factors of Non-Alcoholic Steatohepatitis (NASH) in Morbidly Obese Patients Undergoing Bariatric Surgery , 2006, Obesity surgery.

[111]  G. Tarantino,et al.  Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy , 2005, Annals of Nutrition and Metabolism.

[112]  A. Lazenby,et al.  Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women , 2005, Hepatology.

[113]  Shi-yao Chen,et al.  Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.

[114]  M. Arrese,et al.  Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass , 2005, Obesity surgery.

[115]  G. Bedogni,et al.  Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.

[116]  C. Mottin,et al.  Histological Behavior of Hepatic Steatosis in Morbidly Obese Patients after Weight Loss Induced by Bariatric Surgery , 2005, Obesity surgery.

[117]  E. Bixler,et al.  Sleep apnea is a manifestation of the metabolic syndrome. , 2005, Sleep medicine reviews.

[118]  Z. Goodman,et al.  Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients , 2005, Obesity surgery.

[119]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[120]  A. Suzuki,et al.  Chronological development of elevated aminotransferases in a nonalcoholic population , 2005, Hepatology.

[121]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[122]  S. Malnick,et al.  Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[123]  G. Tarantino,et al.  Silent non-alcoholic fatty liver disease-a clinical-histological study. , 2004, Journal of hepatology.

[124]  A. Lazenby,et al.  Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease , 2004, Hepatology.

[125]  Z. Younossi,et al.  Nonalcoholic fatty liver disease in patients with type 2 diabetes. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[126]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[127]  MD Mph Charles Beymer,et al.  Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. , 2003, Archives of surgery.

[128]  P. Hayashi,et al.  The natural history of nonalcoholic fatty liver disease: a clinical histopathological study , 2003, American Journal of Gastroenterology.

[129]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[130]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[131]  C. Alessandri,et al.  Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases , 2003, Journal of gastroenterology and hepatology.

[132]  P. Giral,et al.  Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.

[133]  A. Di Carlo,et al.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. , 2001, Journal of hepatology.

[134]  R. Fisher,et al.  Selection and outcome of living donors for adult to adult right lobe transplantation. , 2000, Transplantation.

[135]  G. Brandi,et al.  Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.

[136]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[137]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[138]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[139]  M. Bennett,et al.  The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.

[140]  H. Sax.  Long-term morbidity following jejunoileal bypass: the continuing potential need for surgical reversal. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[141]  H. Appelman,et al.  Regression of hepatic steatosis in morbidly obese persons after gastric bypass. , 1995, American journal of clinical pathology.

[142]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.

[143]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[144]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[145]  J. Silverman,et al.  Liver pathology in morbidly obese patients with and without diabetes. , 1990, The American journal of gastroenterology.

[146]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[147]  Randall G. Lee,et al.  Nonalcoholic steatohepatitis: a study of 49 patients. , 1989, Human pathology.

[148]  K. Ewe.  Bleeding after liver biopsy does not correlate with indices of peripheral coagulation , 1981, Digestive Diseases and Sciences.

[149]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[150]  K. Cusi,et al.  Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. , 2014, Journal of hepatology.

[151]  M. Blachier,et al.  Report Title: The burden of liver disease in Europe: a review of available epidemiological data , 2013 .

[152]  M. F. M. Diniz,et al.  Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. , 2012, Arquivos de gastroenterologia.

[153]  R. Hernaez,et al.  Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. , 2012, Gastroenterologia y hepatologia.

[154]  F. Brunello,et al.  Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. , 2011, Journal of hepatology.

[155]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[156]  T. Poynard,et al.  Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. , 2011, Clinics and research in hepatology and gastroenterology.

[157]  K. Petersen,et al.  Apolipoprotein C 3 Gene Variants in Nonalcoholic Fatty Liver Disease , 2010 .

[158]  T. Karlsen.  Genetic variation in PNPLA 3 confers susceptibility to nonalcoholic fatty liver disease , 2009 .

[159]  Z. Younossi.  Practical Management of Liver Diseases: Frontmatter , 2008 .

[160]  J. Stockman.  The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease , 2007 .

[161]  G. Farrell,et al.  LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis , 2006 .

[162]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[163]  J. Everhart,et al.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.

[164]  G. Farrell,et al.  Etiopathogenesis of Nonalcoholic Steatohepatitis , 2001, Seminars in liver disease.

[165]  G. Marchesini,et al.  Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes , 2001, Seminars in liver disease.

[166]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[167]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.

[168]  A. Burt,et al.  Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease , 2022 .